Molecular markers and their prognostic impact in patients with advanced prostate cancer undergoing intermittent androgen suppression.

Autor: Augustin, H.1 herbert.augustin@meduni-graz.at, Freibauer, C.2, Bayer, L.3, Lunglmayr, G.3, Tschurlovich, F.4, Kuber, W.4, Pummer, K.1
Zdroj: Prostate Cancer & Prostatic Diseases. 2006, Vol. 9 Issue 3, p279-283. 5p. 4 Charts, 1 Graph.
Databáze: Academic Search Ultimate